Lippincott ^® NursingCenter ^®

Featured Articles

• Buy

  Advanced Solid Tumors Bevacizumab-Dasatanib Active, Well-Tolerated

  Robert H. Carlson

• Buy

  ASCO Updates Fertility-Preservation Guidelines

  Heather Lindsey

• Buy

  ASCO Updates Guidelines for Prevention and Treatment of VTE in Cancer Patients

  Robert H. Carlson

• Buy

  Breast Cancer: One-Fifth of African American Patients Carry Deleterious Mutations

  Rabiya S. Tuma PhD

• Buy

  Early Breast Cancer: Less Toxicity, Similar Efficacy with Weekly vs. Every-Two Week Paclitaxel

  Rabiya S. Tuma PhD

• Buy

  FDA Approvals for Revlimid for MCL and Xgeva for Giant Cell Tumor of the Bone
• Buy

  For Patients Undergoing Brain Tumor Surgery, Low T3 Syndrome Found to be Biomarker of Poor Outcome—Clinical Implications Remain Unclear

  Heather Lindsey

• Buy

  GM-CSF May Boost Survival in Melanoma Patients Receiving Ipilimumab

  Rabiya S. Tuma PhD

• Buy

  Janet Woodcock: FDA Will Soon Issue Guidance on Co-Development of Drugs and Diagnostics

  Peggy Eastman

• Buy

  Melanoma: Long Overall Survival in Patients Receiving Nivolumab

  Rabiya S. Tuma PhD

• Buy

  New Surveys Document: Cancer Drug Shortages Continue to Affect Patient Care

  Eric T. Rosenthal Special Correspondent

• Buy

  Ovarian Cancer: Pazopanib Maintenance Prolongs Progression-Free Survival

  Rabiya S. Tuma PhD

• Buy

  Survey Says In CML, Imatinib Still Preferred Frontline Treatment for Newly Diagnosed Patients

  Mark Fuerst